Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

    Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

    FromThe Chain: Protein Engineering Podcast

    Start listeningView podcast show

    Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

    FromThe Chain: Protein Engineering Podcast

    ratings:
    Length:
    23 minutes
    Released:
    Mar 18, 2020
    Format:
    Podcast episode

    Description

    Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics.  In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.
    Released:
    Mar 18, 2020
    Format:
    Podcast episode

    Titles in the series (63)

    The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up-to-date on the newest advancements and to hear the stories that are impacting the world of biologics.